Expiration date: 05/2028

The composition and form of issue:

Capsules 1 capsule contains:

the standardized lyophilized bacterial lysates Ha?mophilus influenzae, Streptococcus pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Neisseria catarrhalis 7 mg

excipients: propyl gallate (antioxidant) anhydrous sodium glutamate (cryoprotectant) mannitol (filler) jelatinizirovanny starch (binder) magnesium silicate (curing agent) magnesium stearate (lubricant) indigotin (colorant E 132) titanium oxide (colorant E 171) gelatin 

in a cells contour packing 10 PCs., in box 1 or 3 packs.

Feature:

The lyophilized bacterial lysates.

Pharmacological action:

Ingestion stimulates the body's immune defenses, increases resistance to infections of the respiratory system. Immunopharmacological studies have shown that in humans increases the formation Ig And secreted by respiratory mucosa and saliva, increases the number of circulating T-lymphocytes. In animals, the drug has the following properties: prevents the development of infections, stimulates b-lymphocytes and macrophages.

Clinical pharmacology:

Clinically, the drug reduces the frequency of acute infections, reduces the duration of their course and reduces the severity of symptoms, and reduces the likelihood of exacerbations of chronic diseases. This reduces the need for the use of other drugs, especially antibiotics.

Indications:

Prevention of recurrent respiratory tract infections and exacerbations of chronic bronchitis the complex treatment of acute respiratory tract infections.

Contraindications:

Hypersensitivity to the drug.

Application of pregnancy and breast-feeding:

A study of reproduction in animals showed no risk to fetus, but controlled studies in pregnant women have not been conducted. In relation to nursing special studies have not been conducted, and information is not currently available.

Side effects:

The frequency of mild adverse reactions 3-4%. Manifest as gastrointestinal disorders (nausea, abdominal pain, vomiting), skin reactions (including erythema, itching), disorders of the respiratory system (cough, shortness of breath) and headaches, feelings of fatigue.

Drug interactions:

Interaction with other drugs to date are not installed. The drug can be used concurrently with other drugs used for the treatment of respiratory diseases.

Method of application and dose:

Inside.

For the treatment of acute and exacerbation of chronic respiratory infections: children over 12 and adults — 1 capsule. daily fasting until symptoms disappear, at least 10 days, if necessary, antibiotic therapy is to take in combination with antibiotic from the beginning of treatment. The duration of treatment is determined by the physician based on the individual condition of the patient.

For the prevention of exacerbations and maintenance therapy: children over 12 and adults — 1 capsule. daily in the morning on an empty stomach the treatment consists of 3 cycles, each of which consists of daily dosing for 10 days, the interval between cycles of 20 days.

For children aged 6 months to 12 years who are assigned to baby form, method of application is identical. If the child is difficult to swallow the capsule, open it and mix the contents with a drink (fruit juice, milk, etc.).

Overdose:

Data on overdoses do not exist. The nature of the drug and the results of tests of toxicity conducted on animals indicate that overdose is unlikely.

Precautions:

On the basis of available information to assign children to 6 months is not recommended, because of the immaturity of their immune system. In order to avoid overdose in children should not be used in the preparation of capsules, intended for adults.

In the event of continued gastrointestinal disorders, skin and respiratory manifestations should cease treatment and consult your doctor as they may be symptoms of allergic reactions.

Broncho-Vaxom